CM-4307
未知生产厂商
CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).
CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).
用于治疗既往未接受过全身系统性治疗的不可手术切除或转移性肝细胞癌患者。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
